Intraday BUY SELL Signals
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Feb 05, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a Hold and SPXL is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.62B vs. CURE (163M). SPXL has a higher annual dividend yield than CURE: SPXL (2.140) vs CURE (-2.850). CURE was incepted earlier than SPXL: CURE (15 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -2.850 | 2.140 | -133% |
| Net Assets | 163M | 5.62B | 3% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | N/A | N/A | - |
| Yield | 1.14 | 0.67 | 170% |
| Fund Existence | 15 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | N/A |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 90% | 9 days ago 90% |
| Declines ODDS (%) | 7 days ago 90% | 6 days ago 88% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PEUCX | 41.05 | 0.03 | +0.07% |
| Principal Equity Income C | |||
| PMIVX | 11.46 | -0.01 | -0.09% |
| Putnam Multi-Asset Income R6 | |||
| SVTAX | 10.78 | -0.04 | -0.37% |
| SEI Global Managed Volatility F (SIMT) | |||
| HCMDX | 30.82 | -0.76 | -2.41% |
| HCM Tactical Plus Investor | |||
| MGQAX | 12.57 | -0.43 | -3.31% |
| Morgan Stanley Inst Global Stars A | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | -2.99% | ||
| TMO - CURE | 71% Closely correlated | -2.01% | ||
| DHR - CURE | 68% Closely correlated | -3.05% | ||
| A - CURE | 67% Closely correlated | -2.40% | ||
| MRK - CURE | 67% Closely correlated | +2.18% | ||
| MTD - CURE | 67% Closely correlated | -1.13% | ||
More | ||||
SPXL and
Correlation & Price change
A.I.dvisor indicates that over the last year, SPXL has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPXL jumps, then MSFT could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SPXL | 1D Price Change % | ||
|---|---|---|---|---|
| SPXL | 100% | -2.58% | ||
| MSFT - SPXL | 63% Loosely correlated | -2.87% | ||
| AAPL - SPXL | 62% Loosely correlated | -0.20% | ||
| AMZN - SPXL | 60% Loosely correlated | -1.79% | ||
| META - SPXL | 59% Loosely correlated | -2.08% | ||
| NVDA - SPXL | 56% Loosely correlated | -2.84% | ||
More | ||||